Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes (MID-Frail)
Primary Purpose
Type 2 Diabetes Mellitus
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Exercise, dietary and educational program
Sponsored by

About this trial
This is an interventional prevention trial for Type 2 Diabetes Mellitus
Eligibility Criteria
Inclusion criteria:
- Participant is willing and able to give written informed consent for participation in the study.
- Subjects aged 70 years or older, with a diagnosis of type 2 diabetes mellitus for at least 2 years.
- Require to fulfill Fried ́s criteria for frail or pre-frail individuals.
Exclusion criteria:
- Barthel score lower than 60 points.
- Inability to carry out SPPB test (total score=0).
- Mini Mental State Examination score less than 20 points.
- Subjects unwilling or unable to consent or unable to participate safely in intervention program.
- Previous history of myocardial infarction within 6 months, unstable angina or congestive heart failure in III-IV NYHA stage.
- Clinically instable patients in the clinical judgment of the investigator.
- Terminal illness (life expectancy < 6 months).
- Any other condition that, in the clinical judgment of the investigator, means that it would not in the patient's best interests to enter the study.
- Current participation in clinical trial or any other investigational study.
Sites / Locations
- Hospital Universitario de Getafe
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual Care Group
Intervention Group
Arm Description
Subjects undergo usual standard of care
Intervention with exercise, dietary and educational programs
Outcomes
Primary Outcome Measures
Changes in summary ordinal score on the Short Physical Performance Battery test
The Short Physical Performance Battery (SPPB) is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines 3 areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. These areas represent essential tasks important for independent living and are thus an important outcome measure for patients with cardiovascular and pulmonary disease.
Secondary Outcome Measures
Lawton Instrumental Activity of Daily Living (IADL) scale
Barthel index of activities of daily living
Euro-Quality of Life (QoL) index
Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life,
Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life, using an economic model embracing the direct health-related costs (in-patient, out-patient, pharmaceutical, etc), formal care costs (home care, respite care, day centers, etc) and the informal care costs (carer).
Symptomatic hypoglycaemia
Episodes of symptomatic hypoglycaemia (i.e., a recorded blood sugar less than 4 mmol/L, or symptoms or signs attributed to low blood sugar and responding to appropriate treatment)
Hospital admissions
Episodes of hospital admission (i.e., any admission involving an overnight stay)
Episodes of permanent institutionalization
Episodes of permanent institutionalization (i.e., permanent move to any care setting other than the patient's own home, where paid staff are available to provide care if needed at any time during the day or night).
Caregiver Strain Index
Burden of the carer, as assessed by the modified Caregiver Strain Index
Mortality
Full Information
NCT ID
NCT01654341
First Posted
July 27, 2012
Last Updated
March 25, 2019
Sponsor
Hospital Universitario Getafe
Collaborators
Cardiff University, Igen Biotech SL, University Hospital, Bordeaux, Hexabio Sarl, University of Campania "Luigi Vanvitelli", University Hospital, Toulouse, University of Ulm, University Ghent, University of Castilla-La Mancha, Univerzita Karlova v Praze, Niche Science & Technology Ltd, Catholic University of the Sacred Heart, Vrije Universiteit Brussel, Diabetes Frail Ltd
1. Study Identification
Unique Protocol Identification Number
NCT01654341
Brief Title
Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes
Acronym
MID-Frail
Official Title
A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN FRAIL AND PREFRAIL OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-Frail STUDY
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
December 2013 (undefined)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital Universitario Getafe
Collaborators
Cardiff University, Igen Biotech SL, University Hospital, Bordeaux, Hexabio Sarl, University of Campania "Luigi Vanvitelli", University Hospital, Toulouse, University of Ulm, University Ghent, University of Castilla-La Mancha, Univerzita Karlova v Praze, Niche Science & Technology Ltd, Catholic University of the Sacred Heart, Vrije Universiteit Brussel, Diabetes Frail Ltd
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The MID-Frail STUDY project focuses on the use of interventions designed to improve functional status and enhance quality of life (rather than traditional treatments such as glucose- and blood pressure- lowering) by acting on the mechanisms involved in producing frailty and its progression to adverse outcomes.
Detailed Description
Detailed Description: Subjects enrolled in the main study will also be invited to join the following sub-studies:
GENEFRAIL: this sub-study aims to determine the polymorphisms of several genes associated to frailty, in order to establish its predictive value for developing disability and response to treatment as well METABOFRAIL: this sub-study aims to investigate the metabolomic profile of frail and pre-frail patients. SARTRAIN: the combination of the assessment tools used in SARTRAIN (ARFI US, MRI, posturographic measurements) will provide a comprehensive study of the structural and functional characteristics of muscle and adjacent tissues and their change with time and the intervention. MID- POW: this sub-study aims to investigate changes in muscle power.
The project also include an randomized controlled ancillary study: SENSOLE for which the aim is to investigate the potential effects of vibrating insoles device on gait and posture.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
986 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care Group
Arm Type
No Intervention
Arm Description
Subjects undergo usual standard of care
Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
Intervention with exercise, dietary and educational programs
Intervention Type
Behavioral
Intervention Name(s)
Exercise, dietary and educational program
Primary Outcome Measure Information:
Title
Changes in summary ordinal score on the Short Physical Performance Battery test
Description
The Short Physical Performance Battery (SPPB) is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines 3 areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. These areas represent essential tasks important for independent living and are thus an important outcome measure for patients with cardiovascular and pulmonary disease.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Lawton Instrumental Activity of Daily Living (IADL) scale
Time Frame
2 years
Title
Barthel index of activities of daily living
Time Frame
2 years
Title
Euro-Quality of Life (QoL) index
Time Frame
2 years
Title
Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life,
Description
Economic costs/healthcare expenditure due to diabetes and its impact on disability and quality of life, using an economic model embracing the direct health-related costs (in-patient, out-patient, pharmaceutical, etc), formal care costs (home care, respite care, day centers, etc) and the informal care costs (carer).
Time Frame
2 years
Title
Symptomatic hypoglycaemia
Description
Episodes of symptomatic hypoglycaemia (i.e., a recorded blood sugar less than 4 mmol/L, or symptoms or signs attributed to low blood sugar and responding to appropriate treatment)
Time Frame
2 years
Title
Hospital admissions
Description
Episodes of hospital admission (i.e., any admission involving an overnight stay)
Time Frame
2 years
Title
Episodes of permanent institutionalization
Description
Episodes of permanent institutionalization (i.e., permanent move to any care setting other than the patient's own home, where paid staff are available to provide care if needed at any time during the day or night).
Time Frame
2 years
Title
Caregiver Strain Index
Description
Burden of the carer, as assessed by the modified Caregiver Strain Index
Time Frame
2 years
Title
Mortality
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Participant is willing and able to give written informed consent for participation in the study.
Subjects aged 70 years or older, with a diagnosis of type 2 diabetes mellitus for at least 2 years.
Require to fulfill Fried ́s criteria for frail or pre-frail individuals.
Exclusion criteria:
Barthel score lower than 60 points.
Inability to carry out SPPB test (total score=0).
Mini Mental State Examination score less than 20 points.
Subjects unwilling or unable to consent or unable to participate safely in intervention program.
Previous history of myocardial infarction within 6 months, unstable angina or congestive heart failure in III-IV NYHA stage.
Clinically instable patients in the clinical judgment of the investigator.
Terminal illness (life expectancy < 6 months).
Any other condition that, in the clinical judgment of the investigator, means that it would not in the patient's best interests to enter the study.
Current participation in clinical trial or any other investigational study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leocadio Rodríguez Mañas, MD
Organizational Affiliation
Hospital Universitario de Getafe
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario de Getafe
City
Madrid
State/Province
Getafe
ZIP/Postal Code
28905
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
31316984
Citation
Regueme SC, Cowtan C, Sedgelmaci MY, Kelson M, Poustis J, Rodriguez-Manas L, Sinclair AJ, Dallaudiere B, Bourdel-Marchasson I. A Therapeutic Insole Device for Postural Stability in Older People With Type 2 Diabetes. A Feasibility Study (SENSOLE Part I). Front Med (Lausanne). 2019 Jun 27;6:127. doi: 10.3389/fmed.2019.00127. eCollection 2019.
Results Reference
derived
PubMed Identifier
24456998
Citation
Rodriguez-Manas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ, Moreira S, Cook J; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes--the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34. doi: 10.1186/1745-6215-15-34.
Results Reference
derived
Learn more about this trial
Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes
We'll reach out to this number within 24 hrs